middle.news
BlinkLab Advances FDA Autism Trial and Launches Morocco Screening Program
8:39am on Thursday 30th of April, 2026 AEST
•
Healthcare
Read Story
BlinkLab Advances FDA Autism Trial and Launches Morocco Screening Program
8:39am on Thursday 30th of April, 2026 AEST
Key Points
Completed onboarding of 10 US clinical sites for FDA autism trial
First participant enrolled in pivotal FDA 510(k) validation study
Launched Morocco’s government-led nationwide autism screening
Strengthened US scientific influence via publication and partnerships
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Blinklab (ASX:BB1)
OPEN ARTICLE